Bioequivalence Study to Compare Cariprazine 1.5 mg Hard Capsules (1.5 mg Cariprazine Hydrochloride) Versus Reagila® 1,5 mg Hartkapseln (Hard Capsules) (Cariprazine)
Clinical trial NCT07691190 · COMPLETED
Trial details
- NCT number
- NCT07691190
- Sponsor
- Humanis Saglık Anonim Sirketi
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-05
- Primary completion
- 2026-06-02
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.